EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 60 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,000 | +615.8% | 17,069 | +700.2% | 0.00% | – |
| Q2 2023 | $19,000 | +46.2% | 2,133 | -52.2% | 0.00% | – |
| Q1 2023 | $13,000 | -65.8% | 4,460 | -59.5% | 0.00% | – |
| Q4 2022 | $38,000 | -29.6% | 11,015 | +63.6% | 0.00% | – |
| Q3 2022 | $54,000 | +5.9% | 6,732 | +2.8% | 0.00% | – |
| Q2 2022 | $51,000 | -47.4% | 6,551 | -17.4% | 0.00% | – |
| Q1 2022 | $97,000 | +31.1% | 7,934 | +31.9% | 0.00% | – |
| Q4 2021 | $74,000 | +94.7% | 6,016 | +64.1% | 0.00% | – |
| Q3 2021 | $38,000 | +90.0% | 3,666 | +67.0% | 0.00% | – |
| Q2 2021 | $20,000 | +122.2% | 2,195 | +173.0% | 0.00% | – |
| Q1 2021 | $9,000 | +28.6% | 804 | -24.9% | 0.00% | – |
| Q4 2020 | $7,000 | – | 1,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $33,150,000 | 13.70% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,233,597 | $25,578,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 303,396 | $2,400,000 | 1.03% |
| Samsara BioCapital, LLC | 480,000 | $3,797,000 | 0.88% |
| Altium Capital Management LP | 224,541 | $1,776,000 | 0.65% |
| Monashee Investment Management LLC | 220,000 | $1,740,000 | 0.64% |
| RA Capital Management | 3,370,506 | $26,660,000 | 0.57% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 341,974 | $2,705,000 | 0.43% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 108,285 | $857,000 | 0.29% |
| Orbimed Advisors | 970,860 | $7,680,000 | 0.14% |